A Phase II study of M605106 for axillary osmidrosis

A Randomized, Double-blind, Parallel-group, Multicenter, Exploratory Phase II study to evaluate efficacy and safety of M605106 in patients with axillary osmidrosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2031200184

Enrollment

Registered

2020-11-06

Start date

2020-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

axillary osmidrosis

Interventions

Apply an appropriate amount of investigational drug to the axilla twice daily and remove it after short time application.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: axillary osmidrosis patients

Exclusion criteria

Exclusion criteria: (1)Not suitable for application of investigational drug from the viewpoint of safety, such as a wound on the axilla, or patients with complications or abnormal findings on the axilla affecting safety assessment. (2)Patients judged by the investigator or sub-investigator to have a degree of odor(other than axillary odor) that may affect the evaluation of axillary odor.

Design outcomes

Primary

Measure	Time frame
axillary odor scores	—

Secondary

Measure	Time frame
Adverse events, Laboratory test results	—

Contacts

Public ContactClinical Infomation

Maruho Co.,Ltd. Kyoto R&D Center

ctinfo@mii.maruho.co.jp+81-75-325-3279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026